Article Versions Notes

Raimondi C, Nicolazzo C, Belardinilli F, Loreni F, Gradilone A, Mahdavian Y, Gelibter A, Giannini G, Cortesi E, Gazzaniga P. Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer. Cancers. 2019; 11(1):42. https://doi.org/10.3390/cancers11010042

Raimondi, Cristina, Chiara Nicolazzo, Francesca Belardinilli, Flavia Loreni, Angela Gradilone, Yasaman Mahdavian, Alain Gelibter, Giuseppe Giannini, Enrico Cortesi, and Paola Gazzaniga. 2019. "Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer" Cancers 11, no. 1: 42. https://doi.org/10.3390/cancers11010042

Raimondi, C., Nicolazzo, C., Belardinilli, F., Loreni, F., Gradilone, A., Mahdavian, Y., Gelibter, A., Giannini, G., Cortesi, E., & Gazzaniga, P. (2019). Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer. Cancers, 11(1), 42. https://doi.org/10.3390/cancers11010042